ArticleScientific reports2026
Automated karyotyping and structural anomaly detection through a hybrid multi-stage deep learning framework integrating chromosome detection, pairwise classification, and autoencoder-based analysis.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Manual karyotype analysis remains a labor-intensive and expertise-dependent process that requires visual interpretation of chromosome banding patterns under the microscope. Although recent studies have applied machine learning to isolated stages of chromosome detection, segmentation, or classification, few approaches address the complete cytogenetic workflow in a clinically aligned manner. This work proposes a stability-aware, multi-stage deep learning framework for semi-automated karyotype generation and chromosomal anomaly screening. The pipeline integrates: (i) an overlapped-aware quality-control gate to exclude morphologically unreliable metaphases; (ii) YOLOv8-based single-chromosome detection; (iii) homologous-pair assignment using both a unified YOLOv8 route and a hybrid YOLOv8 + fine-tuned ResNet-50 configuration across 24 chromosome classes; (iv) automatic karyotype assembly; and (v) unsupervised structural anomaly screening via a convolutional autoencoder trained exclusively on normal chromosomes. Experimental validation demonstrated 98.03% detection accuracy (mAP@0.5 = 0.985) and 94.01% validation accuracy for homologous-pair classification. Under sequential modeling, the propagated end-to-end numerical accuracy reached 92.21% for the hybrid configuration and 94.01% for the unified YOLOv8 configuration. The autoencoder exhibited clear separation between normal and structurally anomalous reconstruction-error distributions, enabling effective unsupervised screening without requiring extensive labeled pathological datasets. By explicitly modeling cumulative inter-stage dependency and enforcing morphological integrity through an upstream overlapped filter, the proposed framework provides a clinically interpretable and operationally coherent assistant system. The results demonstrate that stability-aware pipeline design can support both numerical and structural anomaly detection while reducing manual workload and preserving diagnostic transparency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.